A Post-market Clinical Study to Collect Safety and Performance Data on Johnson & Johnson Surgical Vision Products

Prior treatment

• Concurrent participation (during the retrospective follow-up period) in an interventional (drug, device, biologic, etc.) clinical trial
• Use of surgical devices not in accordance with the product labeling or indications for use
• Use of systemic or ocular medications that may affect vision during the retrospective data collection period

Other illness

• Degenerative visual disorders (e.g., macular degeneration or other retinal disorders) that cause visual acuity losses to a level worse than 0.2 logMAR (0.63 decimal, 6/9.5 or 20/32 Snellen) during the retrospective data collection period
• Known ocular disease or pathology that, in the opinion of the investigator may confound study findings during the retrospective data collection period
• Pregnancy, lactating, or other condition associated with hormonal fluctuation that could lead to refractive changes during the retrospective data collection period.

• Patients who have been implanted with and/or undergone ophthalmic surgery using targeted JJSV products
• Status post ophthalmic surgery between 1 day and 24 months for Year 1. Subsequent years after Year 1 will be between 1 day and 18 months.